Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes

Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes

Abstract Background A new special reimbursement scheme (SRS) for non-insulin medications used for treatment of hyperglycaemia in type 2 diabetes (T2D) was implemented in Finland on January 1, 2017. The new SRS affected all community-dwelling Finnish T2D patients as all community-dwelling residents a...

Full description

Bibliographic Details
Main Authors: Piia Lavikainen, Emma Aarnio, Kari Jalkanen, Hilkka Tirkkonen, Päivi Rautiainen, Tiina Laatikainen, Janne Martikainen
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BMC Health Services Research
Subjects:
Type 2 diabetes
Co-payment increase
Glycaemic control
Online Access:https://doi.org/10.1186/s12913-020-05952-6

Internet

https://doi.org/10.1186/s12913-020-05952-6

Similar Items